ABCELLERA BIOLOGICS INC (ABCL) Stock Cash Flow
USA - NASDAQ:ABCL - CA00288U1066 - Common Stock
4.47 USD
-0.14 (-3.04%)
4.5299 USD
+0.06 (+1.34%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -165.66M | -162.86M | -146.40M | 158.50M | 153.50M | |||
| Depreciation Amortization | 69.30M | 97.00M | 30.89M | 27.90M | 14.50M | |||
| Income Taxes - Deferred | N/A | N/A | 1.96M | -2.10M | -2.00M | |||
| Change In Working Capital | 2.83M | -25.84M | 13.22M | 29.80M | 41.70M | |||
| Other non cash items | 12.69M | -16.85M | 56.44M | 63.30M | 37.00M | |||
| OPERATING CASH FLOW | -80.84M | -108.56M | -43.88M | 277.40M | 244.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -58.15M | -78.40M | -77.51M | -72.70M | -58.50M | |||
| Other Investing Activity | 73.67M | 199.81M | -143.60M | -280.00M | -273.80M | |||
| INVESTING CASH FLOW | 15.53M | 121.41M | -221.11M | -352.60M | -332.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -300.00K | -1.00M | |||
| Stock Issued/Repurchased | 23.80M | 13.50M | 11.59M | 2.80M | 4.60M | |||
| Other Financing Activity | -13.92M | -729.00K | -1.23M | -4.10M | -7.60M | |||
| FINANCING CASH FLOW | 9.88M | 12.77M | 10.36M | -1.60M | -3.90M | |||
| Exchange Rate Effect | -442.00K | -2.62M | 589.00K | -9.60M | -1.40M | |||
| CHANGE IN CASH | -55.88M | 23.00M | -254.04M | -86.40M | -92.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -80.84M | -108.56M | -43.88M | 277.40M | 244.60M | |||
| Capital Expenditure | -58.15M | -78.40M | -77.51M | -72.70M | -58.50M | |||
| FREE CASH FLOW | -138.99M | -186.95M | -121.38M | 204.70M | 186.10M | |||
All data in USD